Systematic review

A study that searches for every good piece of research on one question, checks how reliable each one is, and sums up what they show together.

Also called: systematic reviews, evidence review, literature review, review of studies

Related words meta-analysis cochrane review certainty of evidence clinical trial

Topics Research

Questions people ask

What is a Cochrane review and why does it matter?

Cochrane reviews are systematic reviews: researchers find every good trial on a question, judge how reliable each one is and combine the results. They also grade how certain the evidence is. For Crohn's, Cochrane has found strong evidence for some treatments, such as vedolizumab, and too little evidence to judge others, such as treatments for fatigue.

Sources

Can I have treatment for piles if I have Crohn's?

Piles can be treated, but surgery needs care. A 2022 review of studies on piles surgery in people with IBD found the evidence was low quality and concluded that operations in Crohn's should be done cautiously, after other treatments have failed and when the disease is inactive. The NHS describes self-care and pharmacy options for piles; talk to your IBD team before any procedure.

Sources

Is there a special diet I should follow for Crohn's?

No single diet works for everyone with Crohn's. The NHS says there is no clear evidence that a special diet or particular foods help, and a Cochrane review found the trials of exclusion diets too weak to show a benefit. Crohn's & Colitis UK recommends a healthy, balanced diet that gives you enough nutrients, and advises speaking to your IBD team or a dietitian before making big changes or cutting out whole food groups.

Sources

Why am I so tired all the time with Crohn's?

Fatigue is one of the commonest Crohn's symptoms. Crohn's & Colitis UK says it affects around 7 in 10 people during a flare and around 4 in 10 in remission, and has many possible causes. Anaemia from blood loss or poor absorption is one of them, so a blood test is worth asking about. A Cochrane review found only weak evidence so far for specific fatigue treatments.

Sources

Why am I so tired all the time, and what can help?

Fatigue is extreme tiredness that does not go away with rest. Crohn's & Colitis UK says it affects around 7 in 10 people during a flare and around 4 in 10 in remission. Causes include inflammation, anaemia, low nutrients, poor sleep, medicines and low mood. The charity suggests asking your team for blood tests, including for anaemia, and checking your medicines. Being active can help. A Cochrane review found the evidence for specific fatigue treatments still uncertain.

Sources

Where to read more

Psychological interventions in inflammatory bowel disease

Cochrane Systematic review Apr 2025 Patients and professionals

A plain-language summary of a Cochrane review. It concludes that psychological treatments probably give a small improvement in quality of life, depression and anxiety in adults with IBD, and probably improve quality of life in teenagers. Any effect on inflammation or physical symptoms is very uncertain.

Topics Mental health Research

Jargon explained psychological interventions systematic review

Treatments for extreme tiredness and lack of energy (fatigue) in inflammatory bowel disease

Cochrane Systematic review Apr 2020 Patients and professionals

A Cochrane review of 14 studies, covering both drug and non-drug treatments such as exercise and psychological approaches, for fatigue in IBD. The reviewers concluded the evidence is too uncertain to say which treatments work and called for trials designed specifically around fatigue.

Topics Fatigue Research

Jargon explained fatigue systematic review

Effectiveness of smoking cessation interventions for smokers with Crohn's disease: a systematic review

Future Science OA (PubMed Central) Systematic review 2023 For professionals

An open-access review of studies on helping people with Crohn's stop smoking. Its background summarises evidence that smokers with Crohn's have more flares and operations and that people who quit can do as well as non-smokers. It concludes that stop-smoking support tailored to people with Crohn's needs more study.

Topics Living well Research

Jargon explained smoking cessation systematic review

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

Cochrane Systematic review Oct 2015 Patients and professionals

Cochrane pooled the trials of azathioprine and mercaptopurine for keeping Crohn's quiet. Low-quality evidence suggests azathioprine works better than placebo, but side effects such as pancreatitis, low white cell counts, sickness and infections limit its use. More good-quality trials are needed.

Topics Immunosuppressants Research

Jargon explained thiopurine low-quality evidence adverse event remission placebo systematic review

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

The Lancet Systematic review Dec 2017 For professionals

A review of population studies from around the world. In Western countries the number of new cases is levelling off but more than 0.3% of people now live with IBD. In newly industrialised countries in Asia, Africa and South America, new cases are rising quickly as lifestyles become more Western.

Topics About Crohn's disease Research

Jargon explained systematic review incidence prevalence population-based study

Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy

BMJ Open via PubMed Central Systematic review 2019 For professionals

A UK review pooling studies of how accurate the calprotectin poo test is at detecting IBD in adults with long-standing gut symptoms. Only a handful of the eligible studies were done in general practice, and the results varied too much between studies to compare GP and hospital settings properly. It is useful background on why calprotectin helps but is not a perfect test.

Topics Diagnosis and tests Research

Jargon explained faecal calprotectin sensitivity specificity meta-analysis

Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta-Analysis

Journal of Clinical Medicine Systematic review Jan 2022 For professionals

Pulls together 10 small retrospective studies of piles surgery in 222 people with IBD. Evidence quality was low; the authors conclude that surgery for piles in Crohn's should be done with caution, only when other treatments have failed and the disease is inactive.

Topics Around the bottom (perianal) Bleeding from the bottom Surgery

Jargon explained haemorrhoids haemorrhoidectomy rubber band ligation

Efficacy of different psychological interventions for the treatment of inflammatory bowel disease: a systematic review and network meta-analysis

Frontiers in Medicine (PubMed Central) Systematic review 2025 For professionals

A 2025 open-access analysis comparing types of psychological therapy for people with IBD. Mindfulness and CBT reduced depression, acceptance and commitment therapy and CBT reduced anxiety, and CBT ranked well for stress. The authors see these therapies as useful additions to medical care, with uncertain effects on disease activity.

Topics Mental health Research

Jargon explained cognitive behavioural therapy mindfulness acceptance and commitment therapy network meta-analysis

Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease

Cochrane Systematic review May 2025 Patients and professionals

Updated Cochrane review of ustekinumab (Stelara) and related drugs for active Crohn's. It found ustekinumab helps bring on remission by eight weeks and probably does not cause more serious side effects than placebo. There was not enough data to choose the best dose for children, and comparisons with other biologics are very uncertain.

Topics Biologics and newer medicines

Jargon explained IL-12/23 induction certainty of evidence

Vedolizumab for induction and maintenance of remission in Crohn's disease

Cochrane Systematic review Jul 2023 Patients and professionals

Pooling several trials, Cochrane found high-certainty evidence that vedolizumab (Entyvio) works better than placebo both for bringing on remission and keeping it. Overall side effects were probably similar to placebo. Head-to-head comparisons with other biologics are still needed.

Topics Biologics and newer medicines Research

Jargon explained high-certainty evidence induction maintenance integrin

Search everything for "systematic review"